Inventor · disambiguated record
Allen Hopper
Also filed as: HOPPER ALLEN · HOPPER ALLEN T · HOPPER ALLEN TAYLOR
41 granted patents·57 pending applications·260 citations·filing 1994–2023
97Inventor score
Files withMEMORY PHARM CORP24REMIX THERAPEUTICS INC17ARRINGTON MARK P5LIU RUIPING4SCHUMACHER RICHARD A4
Top patents by PatentIndex Score
98 records- 0187US7655802B2Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogsMEMORY PHARM CORP·Filed 2006·Granted Feb 2, 2010·9 cites·35 claims
- 0287US6699890B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2002·Granted Mar 2, 2004·21 cites·75 claims
- 0386US9796664B2Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitorsBIOMARIN PHARM INC·Filed 2016·Granted Oct 24, 2017·5 cites·19 claims
- 0486US7226930B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2004·Granted Jun 5, 2007·27 cites·37 claims
- 0585US7087625B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2003·Granted Aug 8, 2006·24 cites·84 claims
- 0684US9102591B2BenzamidesLUNDBECK & CO AS H·Filed 2013·Granted Aug 11, 2015·6 cites·22 claims
- 0781US9265734B2Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitorsRUSCHE JAMES R·Filed 2009·Granted Feb 23, 2016·8 cites·39 claims
- 0881US7700631B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2006·Granted Apr 20, 2010·5 cites·19 claims
- 0979US7153871B2Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogsMEMORY PHARM CORP·Filed 2003·Granted Dec 26, 2006·9 cites·40 claims
- 1077US7244745B2Heterocyclic compounds, methods for the preparation thereof, and uses thereofMEMORY PHARM CORP·Filed 2003·Granted Jul 17, 2007·8 cites·69 claims
- 1175US7723348B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2008·Granted May 25, 2010·2 cites·61 claims
- 1275US7585882B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2005·Granted Sep 8, 2009·2 cites·35 claims
- 1375US7495017B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2007·Granted Feb 24, 2009·2 cites·45 claims
- 1474US7235579B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2002·Granted Jun 26, 2007·8 cites·48 claims
- 1574US6162824ATricylic amino-acid derivativesALLELIX NEUROSCIENCE INC·Filed 1999·Granted Dec 19, 2000·17 cites·19 claims
- 1672US7576080B2Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitorsMEMORY PHARM CORP·Filed 2005·Granted Aug 18, 2009·2 cites·43 claims
- 1772US6262073B1Pharmaceutical methods of use of 5-substituted and 5,5 disubstituted-3,4-dihydroxy-2(5H)-furanonesOXIS INTERNAT INC·Filed 2000·Granted Jul 17, 2001·5 cites·11 claims
- 1871US10774073B2Compositions and methods for treating infectionsVYERA PHARMACEUTICALS LLC·Filed 2017·Granted Sep 15, 2020·1 cites·21 claims
- 1971US9649308B2Benzamide-containing compounds and their use in the treatment of painH LUNDBECK AS·Filed 2015·Granted May 16, 2017·1 cites·23 claims
- 2071US7432266B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2005·Granted Oct 7, 2008·1 cites·57 claims
- 2170US7405230B2Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogsMEMORY PHARM CORP·Filed 2003·Granted Jul 29, 2008·5 cites·39 claims
- 2268US7332486B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2003·Granted Feb 19, 2008·3 cites·33 claims
- 2368US6667336B2GlyT-1 inhibitorsNPS ALLELIX CORP·Filed 2002·Granted Dec 23, 2003·4 cites·66 claims
- 2468US6166072AAmino acid derivativesALLELIX NEUROSCIENCE INC·Filed 1999·Granted Dec 26, 2000·12 cites·25 claims
- 2566US6005000A5,5-Disubstituted-3, 4-dihydroxy-2(5H)-furanones and methods of use thereforOXIS INT INC·Filed 1997·Granted Dec 21, 1999·16 cites·15 claims
- 2664US2023312522A1Cyp46a1 inhibitors and methods of use thereofSAGE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2764US2009325982A1Phosphodiesterase 4 inhibitorsHOPPER ALLEN T·Filed 2009·Application pending·0 cites
- 2863US2025170112A1Adenosine ligands for the treatment of neurological disordersLUCY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2962US6265436B1Substituted 5-biphenyl-3,4-dihydroxy-2(5H)-furanones and method of use thereforOXIS THERAPEUTICS INC·Filed 1999·Granted Jul 24, 2001·17 cites·35 claims
- 3062US2010004236A1Phosphodiesterase 4 inhibitorsTEHIM ASHOK·Filed 2009·Application pending·0 cites
- 3161US7696198B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2004·Granted Apr 13, 2010·1 cites·17 claims
- 3260US8440837B22-substituted-ethynylthiazole derivatives and uses of sameHOPPER ALLEN·Filed 2010·Granted May 14, 2013·1 cites·16 claims
- 3360US2008269260A1Phosphodiesterase 4 inhibitorsHOPPER ALLEN T·Filed 2008·Application pending·0 cites
- 3460US2025109140A15-[5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseasesREMIX THERAPUTICS INC·Filed 2023·Application pending·0 cites
- 3560US2010010020A1Phosphodiesterase 4 inhibitorsLIU RUIPING·Filed 2009·Application pending·0 cites
- 3659US7700630B2Heterocyclic compounds, methods for the preparation thereof, and uses thereofMEMORY PHARM CORP·Filed 2007·Granted Apr 20, 2010·0 cites·33 claims
- 3759US5399721ASynthesis of optically pure 4-aryl-2-hydroxytetronic acidsUNIV OHIO STATE RES FOUND·Filed 1994·Granted Mar 21, 1995·6 cites·10 claims
- 3859US2025082633A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3959US2009176799A1Phosphodiesterase 4 inhibitorsRUIPING LIU·Filed 2008·Application pending·0 cites
- 4059US2008139583A1Phosphodiesterase 4 inhibitorsTEHIM ASHOK·Filed 2008·Application pending·0 cites
- 4159US2010093806A1Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogsSCHUMACHER RICHARD A·Filed 2009·Application pending·0 cites
- 4259US2023365526A1Pyridazine derivatives for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4359US2023140983A1Pyridazine derivatives for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4459US2025326748A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4559US2025092065A12-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseasesREMIX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4658US11530198B2Compositions and methods for treating infectionsVYERA PHARMACEUTICALS LLC·Filed 2020·Granted Dec 20, 2022·0 cites·18 claims
- 4758US7205320B2Phosphodiesterase 4 inhibitorsMEMORY PHARM CORP·Filed 2004·Granted Apr 17, 2007·2 cites·71 claims
- 4858US2023159496A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4958US2024366612A1Compounds and methods for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 5058US2025332173A1Compounds and methods for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 98 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Allen Hopper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →